| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 86.971 | 99.081 | 140.709 | 130.207 | 124.763 | 136.125 | 144.587 | 171.458 | 203.166 | 181.487 |
| Total Income - EUR | 87.311 | 99.632 | 141.647 | 130.894 | 127.914 | 138.111 | 145.204 | 172.099 | 203.547 | 181.540 |
| Total Expenses - EUR | 9.308 | 7.660 | 18.514 | 23.837 | 20.858 | 31.184 | 43.045 | 48.721 | 64.907 | 112.139 |
| Gross Profit/Loss - EUR | 78.003 | 91.972 | 123.133 | 107.057 | 107.056 | 106.928 | 102.158 | 123.378 | 138.640 | 69.402 |
| Net Profit/Loss - EUR | 65.024 | 88.994 | 121.717 | 105.753 | 105.791 | 105.690 | 100.740 | 121.954 | 136.604 | 64.482 |
| Employees | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 2 | 1 |
Check the financial reports for the company - Pharma Queen Consult Services Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 94 | 18 | 0 | 0 | 0 | 4.050 | 47.737 | 39.825 | 27.269 | 34.992 |
| Current Assets | 89.622 | 98.926 | 139.661 | 117.906 | 122.289 | 144.107 | 101.795 | 114.920 | 152.505 | 114.429 |
| Inventories | 681 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.707 | 4.353 |
| Receivables | 11.259 | 11.136 | 11.798 | 23.230 | 27.611 | 55.557 | 73.798 | 156.995 | 107.261 | 60.182 |
| Cash | 77.683 | 87.790 | 127.863 | 94.676 | 94.678 | 88.550 | 27.997 | -42.076 | 43.537 | 49.895 |
| Shareholders Funds | 77.328 | 89.038 | 121.760 | 105.796 | 105.841 | 105.739 | 100.789 | 122.003 | 141.152 | 96.690 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.872 | 9.906 | 17.901 | 12.110 | 16.536 | 42.781 | 51.104 | 38.155 | 34.292 | 46.850 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.331 | 5.882 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Pharma Queen Consult Services Srl